proxyvotesnow.com

Home › Companies › Arcturus Therapeutics Holdings Inc. › 2024-2025

Arcturus Therapeutics Holdings Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed 2025-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 13Reported items
  • 175Asset managers
  • 2,034Fund votes
  • 2025-06-06Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Arcturus Therapeutics Holdings Inc.

These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Arcturus Therapeutics Holdings Inc. — official shareholder meeting results, meeting held 2025-06-06
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
The proposal was approved. Proposal No. 3 21,971,16830,5894,767 ---- Majority: yes

Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on 2025-06-06 — read the filing on EDGAR.

How asset managers voted at the Arcturus Therapeutics Holdings Inc. 2024-2025 meeting

Each item below shows how the 175 asset managers that disclosed a Arcturus Therapeutics Holdings Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Arcturus Therapeutics Holdings Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 169 asset managers below cast 98% of the shares they voted on this item FOR (20,835,569 for, 454,223 against).

FOR: 20,835,569 (97.9%)AGAINST: 454,223 (2.1%)
Largest asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes9,388,1200 00For
ARK ETF Trust1,970,6730 00For
Nikko Asset Management Co., Ltd.1,927,1050 00For
Vanguard1,765,4350 00For
BlackRock1,662,2483,271 00For
Fidelity333,737113,692 00For
State Street423,3717,810 00For
Charles Schwab391,8180 00For
Woodline Partners LP366,7900 00For
JUPITER ASSET MANAGEMENT LTD361,0800 00For
GEODE CAPITAL MANAGEMENT, LLC334,2190 00For
Vestal Point Capital, LP273,4670 00For
Dimensional179,8020 00For
Northern Trust147,228117 00For
Goldman Sachs138,1510 00For
JACOBS LEVY EQUITY MANAGEMENT, INC115,0590 00For
American Century0106,318 00Against
STATE OF WISCONSIN INVESTMENT BOARD80,1790 00For
Wellington67,5670 00For
Equitable63,1140 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/060,129 00Against
MFS060,129 00Against
Nuveen55,9250 00For
TIAA54,7920 00For
Putnam52,1410 00For

Showing the 25 largest of 169 asset managers. See all 169 in the interactive database.

2. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 53 asset managers below cast 100% of the shares they voted on this item FOR (10,821,309 for, 0 against).

FOR: 10,821,309 (100.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Investment Managers Series Trust II18,3220 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For

Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.

3. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,667,200 for, 0 against).

FOR: 10,667,200 (98.7%)ABSTAIN: 135,787 (1.3%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 22,8000For
MFS00 60,1290Abstain
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust00 16,7160Abstain
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X00 13,4740Abstain
WisdomTree12,3910 00For
Columbia Threadneedle00 11,7750Abstain
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

4. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.4%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,746,209 for, 0 against).

FOR: 10,746,209 (99.5%)ABSTAIN: 56,778 (0.5%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 56,2370For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

5. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.7%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,780,187 for, 0 against).

FOR: 10,780,187 (99.8%)ABSTAIN: 22,800 (0.2%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 22,8000For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

6. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.4%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,746,209 for, 0 against).

FOR: 10,746,209 (99.5%)ABSTAIN: 56,778 (0.5%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 56,2370For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

7. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,802,987 for, 0 against).

FOR: 10,802,987 (100.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

8. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,800,670 for, 0 against).

FOR: 10,800,670 (100.0%)ABSTAIN: 2,317 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

9. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.2%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,723,409 for, 0 against).

FOR: 10,723,409 (99.3%)ABSTAIN: 79,578 (0.7%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity333,7370 56,2370For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable40,3140 22,8000For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

10. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

DIRECTOR ELECTIONS

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 52 asset managers below cast 100% of the shares they voted on this item FOR (10,802,987 for, 0 against).

FOR: 10,802,987 (100.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Charles Schwab195,9090 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,8560 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
Global X13,4740 00For
WisdomTree12,3910 00For
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For

Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.

11. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Andy Sassine

DIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.7%

The 46 asset managers below cast 100% of the shares they voted on this item FOR (5,878,145 for, 0 against).

FOR: 5,878,145 (99.8%)ABSTAIN: 12,648 (0.2%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust1,970,6730 00For
Vanguard1,704,5670 00For
BlackRock1,021,5300 00For
Fidelity389,9740 00For
Dimensional137,0950 00For
Goldman Sachs75,7140 00For
Equitable63,1140 00For
MFS60,1290 00For
State Street59,6990 00For
TIAA54,7920 00For
American Century53,0030 00For
QUANTITATIVE MASTER SERIES LLC39,1700 00For
Lincoln Financial34,7670 00For
JPMorgan24,1070 00For
Nationwide21,4240 00For
Putnam17,7710 00For
Northern Trust16,7160 00For
Direxion Shares ETF Trust16,2830 00For
ProShares14,6020 00For
WisdomTree00 12,3910Abstain
Columbia Threadneedle11,7750 00For
AIG/SunAmerica11,7030 00For
Jacob Funds Inc.8,4500 00For
John Hancock8,4500 00For
ALPS ETF Trust8,4220 00For

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

12. Elect Andrew H. Sassine

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 99.6%

The 7 asset managers below cast 100% of the shares they voted on this item FOR (4,894,705 for, 0 against).

FOR: 4,894,705 (99.6%)ABSTAIN: 17,489 (0.4%)
Largest asset managers voting on “Elect Andrew H. Sassine” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,694,0600 00For
Charles Schwab195,9090 00For
Global X00 13,4740Abstain
Russell Investments4,7360 00For
SEI00 3,1000Abstain
NEW COVENANT FUNDS00 4830Abstain
Nationwide00 4320Abstain

13. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTES

70% fund support · no official result

FOR 70%AGAINST 30%

The 2 asset managers below cast 70% of the shares they voted on this item FOR (224,067 for, 94,419 against).

FOR: 224,067 (70.4%)AGAINST: 94,419 (29.6%)
Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at Arcturus Therapeutics Holdings Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
JPMorgan224,0670 00For
NORDEA INVESTMENT MANAGEMENT AB094,419 00Against

Largest Arcturus Therapeutics Holdings Inc. shareholders voting in 2024-2025

Ranked by the number of Arcturus Therapeutics Holdings Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 27,000,000 shares outstanding at the time of that meeting.

Top Arcturus Therapeutics Holdings Inc. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Federated Hermes 34.77%
2ARK ETF Trust 7.30%
3Nikko Asset Management Co., Ltd. 7.14%
4Vanguard 6.54%
5BlackRock 6.17%
6Fidelity 1.66%
7State Street 1.60%
8Charles Schwab 1.45%
9Woodline Partners LP 1.36%
10JUPITER ASSET MANAGEMENT LTD 1.34%

Reported Arcturus Therapeutics Holdings Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Arcturus Therapeutics Holdings Inc. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Federated Hermes, Inc. 12.24% 13G
ARK Investment Management LLC 10.92% 13G
BlackRock 10.22% 13F
Amova Asset Management Americas, Inc. 7.21% 13G
Vanguard Group 6.48% 13F
State Street 4.74% 13F
Dimensional Fund Advisors 2.28% 13F
Geode Capital 2.11% 13F
Morgan Stanley 2.04% 13F
Goldman Sachs 1.89% 13F

Percentages above are of 27,000,000 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-K dated 2024-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-K dated 2024-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held 2025-06-06, in the 2024-2025 proxy season, 175 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,034 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Arcturus Therapeutics Holdings Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.